Prevention of Neural Tube Defects in Europe: A Public Health Failure
Objective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first t...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2021.647038/full |
id |
doaj-57a0c1d9d13544888581528d0d4764a7 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joan K. Morris Marie-Claude Addor Elisa Ballardini Ingeborg Barisic Laia Barrachina-Bonet Paula Braz Clara Cavero-Carbonell Elly Den Hond Ester Garne Miriam Gatt Martin Haeusler Babak Khoshnood Nathalie Lelong Agnieszka Kinsner-Ovaskainen Sonja Kiuru-Kuhlefelt Kari Klungsoyr Kari Klungsoyr Anna Latos-Bielenska Elizabeth Limb Mary T O'Mahony Isabelle Perthus Anna Pierini Judith Rankin Anke Rissmann Florence Rouget Gerardine Sayers Antonin Sipek Sarah Stevens David Tucker Christine Verellen-Dumoulin Hermien E. K. de Walle Diana Wellesley Wladimir Wertelecki Eva Bermejo-Sanchez |
spellingShingle |
Joan K. Morris Marie-Claude Addor Elisa Ballardini Ingeborg Barisic Laia Barrachina-Bonet Paula Braz Clara Cavero-Carbonell Elly Den Hond Ester Garne Miriam Gatt Martin Haeusler Babak Khoshnood Nathalie Lelong Agnieszka Kinsner-Ovaskainen Sonja Kiuru-Kuhlefelt Kari Klungsoyr Kari Klungsoyr Anna Latos-Bielenska Elizabeth Limb Mary T O'Mahony Isabelle Perthus Anna Pierini Judith Rankin Anke Rissmann Florence Rouget Gerardine Sayers Antonin Sipek Sarah Stevens David Tucker Christine Verellen-Dumoulin Hermien E. K. de Walle Diana Wellesley Wladimir Wertelecki Eva Bermejo-Sanchez Prevention of Neural Tube Defects in Europe: A Public Health Failure Frontiers in Pediatrics neural tube defects prevention folic acid fortification Europe |
author_facet |
Joan K. Morris Marie-Claude Addor Elisa Ballardini Ingeborg Barisic Laia Barrachina-Bonet Paula Braz Clara Cavero-Carbonell Elly Den Hond Ester Garne Miriam Gatt Martin Haeusler Babak Khoshnood Nathalie Lelong Agnieszka Kinsner-Ovaskainen Sonja Kiuru-Kuhlefelt Kari Klungsoyr Kari Klungsoyr Anna Latos-Bielenska Elizabeth Limb Mary T O'Mahony Isabelle Perthus Anna Pierini Judith Rankin Anke Rissmann Florence Rouget Gerardine Sayers Antonin Sipek Sarah Stevens David Tucker Christine Verellen-Dumoulin Hermien E. K. de Walle Diana Wellesley Wladimir Wertelecki Eva Bermejo-Sanchez |
author_sort |
Joan K. Morris |
title |
Prevention of Neural Tube Defects in Europe: A Public Health Failure |
title_short |
Prevention of Neural Tube Defects in Europe: A Public Health Failure |
title_full |
Prevention of Neural Tube Defects in Europe: A Public Health Failure |
title_fullStr |
Prevention of Neural Tube Defects in Europe: A Public Health Failure |
title_full_unstemmed |
Prevention of Neural Tube Defects in Europe: A Public Health Failure |
title_sort |
prevention of neural tube defects in europe: a public health failure |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pediatrics |
issn |
2296-2360 |
publishDate |
2021-06-01 |
description |
Objective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA.Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation.Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements.Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year. |
topic |
neural tube defects prevention folic acid fortification Europe |
url |
https://www.frontiersin.org/articles/10.3389/fped.2021.647038/full |
work_keys_str_mv |
AT joankmorris preventionofneuraltubedefectsineuropeapublichealthfailure AT marieclaudeaddor preventionofneuraltubedefectsineuropeapublichealthfailure AT elisaballardini preventionofneuraltubedefectsineuropeapublichealthfailure AT ingeborgbarisic preventionofneuraltubedefectsineuropeapublichealthfailure AT laiabarrachinabonet preventionofneuraltubedefectsineuropeapublichealthfailure AT paulabraz preventionofneuraltubedefectsineuropeapublichealthfailure AT claracaverocarbonell preventionofneuraltubedefectsineuropeapublichealthfailure AT ellydenhond preventionofneuraltubedefectsineuropeapublichealthfailure AT estergarne preventionofneuraltubedefectsineuropeapublichealthfailure AT miriamgatt preventionofneuraltubedefectsineuropeapublichealthfailure AT martinhaeusler preventionofneuraltubedefectsineuropeapublichealthfailure AT babakkhoshnood preventionofneuraltubedefectsineuropeapublichealthfailure AT nathalielelong preventionofneuraltubedefectsineuropeapublichealthfailure AT agnieszkakinsnerovaskainen preventionofneuraltubedefectsineuropeapublichealthfailure AT sonjakiurukuhlefelt preventionofneuraltubedefectsineuropeapublichealthfailure AT kariklungsoyr preventionofneuraltubedefectsineuropeapublichealthfailure AT kariklungsoyr preventionofneuraltubedefectsineuropeapublichealthfailure AT annalatosbielenska preventionofneuraltubedefectsineuropeapublichealthfailure AT elizabethlimb preventionofneuraltubedefectsineuropeapublichealthfailure AT marytomahony preventionofneuraltubedefectsineuropeapublichealthfailure AT isabelleperthus preventionofneuraltubedefectsineuropeapublichealthfailure AT annapierini preventionofneuraltubedefectsineuropeapublichealthfailure AT judithrankin preventionofneuraltubedefectsineuropeapublichealthfailure AT ankerissmann preventionofneuraltubedefectsineuropeapublichealthfailure AT florencerouget preventionofneuraltubedefectsineuropeapublichealthfailure AT gerardinesayers preventionofneuraltubedefectsineuropeapublichealthfailure AT antoninsipek preventionofneuraltubedefectsineuropeapublichealthfailure AT sarahstevens preventionofneuraltubedefectsineuropeapublichealthfailure AT davidtucker preventionofneuraltubedefectsineuropeapublichealthfailure AT christineverellendumoulin preventionofneuraltubedefectsineuropeapublichealthfailure AT hermienekdewalle preventionofneuraltubedefectsineuropeapublichealthfailure AT dianawellesley preventionofneuraltubedefectsineuropeapublichealthfailure AT wladimirwertelecki preventionofneuraltubedefectsineuropeapublichealthfailure AT evabermejosanchez preventionofneuraltubedefectsineuropeapublichealthfailure |
_version_ |
1721361546857152512 |
spelling |
doaj-57a0c1d9d13544888581528d0d4764a72021-06-24T05:53:23ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-06-01910.3389/fped.2021.647038647038Prevention of Neural Tube Defects in Europe: A Public Health FailureJoan K. Morris0Marie-Claude Addor1Elisa Ballardini2Ingeborg Barisic3Laia Barrachina-Bonet4Paula Braz5Clara Cavero-Carbonell6Elly Den Hond7Ester Garne8Miriam Gatt9Martin Haeusler10Babak Khoshnood11Nathalie Lelong12Agnieszka Kinsner-Ovaskainen13Sonja Kiuru-Kuhlefelt14Kari Klungsoyr15Kari Klungsoyr16Anna Latos-Bielenska17Elizabeth Limb18Mary T O'Mahony19Isabelle Perthus20Anna Pierini21Judith Rankin22Anke Rissmann23Florence Rouget24Gerardine Sayers25Antonin Sipek26Sarah Stevens27David Tucker28Christine Verellen-Dumoulin29Hermien E. K. de Walle30Diana Wellesley31Wladimir Wertelecki32Eva Bermejo-Sanchez33Population Health Research Institute, St. George's, University of London, London, United KingdomDepartment of Woman-Mother-Child, University Hospital Center, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, SwitzerlandIndagine Sulle Malformazioni Congenite in Emilia-Romagna (IMER) Registry (Emilia Romagna Registry of Birth Defects) Neonatal Intensive Care Unit, Pediatric Section Department of Medical Sciences, University of Ferrara, Ferrara, ItalyCentre of Excellence for Reproductive and Regenerative Medicine, Children's Hospital Zagreb, Medical School University of Zagreb, Zagreb, CroatiaRare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, SpainEpidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisboa, PortugalRare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, SpainHealth Department, Provincial Institute of Hygiene, Antwerp, BelgiumPaediatric Department, Hospital Lillebaelt Kolding, Kolding, DenmarkDirectorate for Health Information and Research, Pietà, Malta0Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria1Université de Paris, Center of Research in Epidemiology and StatisticS/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France1Université de Paris, Center of Research in Epidemiology and StatisticS/CRESS/Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France2European Commission, Joint Research Centre, Ispra, Italy3Finnish Institute for Health and Welfare Terveyden Ja Hyvinvoinnin Laitos (THL), Register of Congenital Malformations, Helsinki, Finland4Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway5Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway6Department of Medical Genetics, Poznan University of Medical Sciences, Poznan, PolandPopulation Health Research Institute, St. George's, University of London, London, United Kingdom7Health Service Executive-South, Department of Public Health, St. Finbarr's Hospital, Cork, Ireland8Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, CHU Estaing, Clermont-Ferrand, France9Institute of Clinical Physiology, National Research Council, Pisa, Italy0Population Health Sciences Institute, Newcastle University, Newcastle, United Kingdom1Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke-University, Magdeburg, Germany2Brittany Registry of Congenital Anomalies, CHU Rennes, Univ Rennes, INSERM, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France3Health Intelligence R&D Health Service Executive, Dublin, Ireland4Department of Medical Biology and Genetics, 1st Faculty of Medicine, General University Hospital, Charles University, Prague, Czechia5Public Health England, London, United Kingdom6Congenital Anomaly Register and Information Service for Wales, Public Health Wales Knowledge Directorate, Singleton Hospital, Swansea, United Kingdom7Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Charleroi, Belgium8Department of Genetics, Eurocat Northern Netherlands, University of Groningen, University Medical Center Groningen, Groningen, Netherlands9Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom0OMNI-Net Ukraine Programs, Rivne, Ukraine1Spanish Collaborative Study of Congenital Malformations (ECEMC), Unidad de Investigación sobre Anomalías Congénitas, Institute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, Madrid, SpainObjective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA.Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation.Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements.Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year.https://www.frontiersin.org/articles/10.3389/fped.2021.647038/fullneural tube defectspreventionfolic acidfortificationEurope |